Really nice to have met my former thesis advisor, Dr. Dmitry Gabrilovich with who I never had the chance to say goodbye after my defense in 2020 due to COVID-19. Two years after, we finally had our long overdue dinner celebration! Truly appreciate his mentorship & guidance. 🙏🏼
Veglia et al. @GabrilovichLab characterize the heterogeneity of polymorphonuclear neutrophils (PMNs) in cancer. The identification of neutrophil populations with potent immune suppressive activity opens selective targeting opportunities. bit.ly/3a7jqOR#Tumorimmunology
This study from the Gabrilovich lab characterized the heterogeneity of polymorphonuclear #neutrophils (PMNs) in #cancer. The identification of neutrophil populations w/ potent immune suppressive activity opens selective targeting opportunities. bit.ly/3a7jqOR
Congratulations to @TheWistar’s Dr. Dmitry I. Gabrilovich on receiving the most prestigious research grant from the @AmericanCancer to further his groundbreaking research in tumor immunology. bit.ly/30Kfzzl
Thrilled to share our latest work on FATP2 as a new regulator of suppressive functions of neutrophils in cancer. @nature@gabrilovichlab @TheWistarInstitute
Fatty acid transport protein 2 reprograms neutrophils in cancer disq.us/t/3drzguk
Jade Matthews-Balcombe, a biology major @BklynCollege411, is part of the #PennSUIP@Penn, & this summer she is working in the @GabrilovichLab@TheWistar under the mentorship of @aliceak15 developing a new immunotherapy-based approach to target immune suppressor cells in cancer